# Fidelity Advisor Biotechnology Fund

Fidelity Advisor Biotechnology Fund is a registered fund series of Fidelity Advisor Series VII (series S000005321). Net assets $1.9B as of 2026-04-30.

## Profile

- Series ID: S000005321
- Registrant: Fidelity Advisor Series VII
- LEI: C7UWI9NYV6ZT61IPLX72
- Net assets: $1.9B
- Total assets: $2.0B
- As of: 2026-04-30

## Advisers

- [FMR Investment Management (UK) Limited (Subadvisor)](https://search.stillhousedata.com/firm/108273)
- [Fidelity Management & Research Company LLC (Advisor)](https://search.stillhousedata.com/firm/108281)
- [Fidelity Management & Research (Hong Kong) Limited (Subadvisor)](https://search.stillhousedata.com/firm/148045)
- [Fidelity Management & Research (Japan) Limited (Subadvisor)](https://search.stillhousedata.com/firm/148239)

## Top holdings (98 reported)

_Showing 15 of 98 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [ABBVIE INC](https://search.stillhousedata.com/security/00287Y109) | — | $282.2M | 1482.70% |
| [ALNYLAM PHARMACEUTICALS INC](https://search.stillhousedata.com/security/02043Q107) | — | $105.1M | 552.01% |
| [GILEAD SCIENCES INC](https://search.stillhousedata.com/security/375558103) | — | $103.2M | 542.30% |
| [INSMED INC](https://search.stillhousedata.com/security/457669307) | — | $66.7M | 350.68% |
| [COGENT BIOSCIENCES INC](https://search.stillhousedata.com/security/19240Q201) | — | $65.7M | 345.01% |
| [DIANTHUS THERAPEUTICS INC](https://search.stillhousedata.com/security/252828108) | — | $64.1M | 336.77% |
| [SPYRE THERAPEUTICS INC](https://search.stillhousedata.com/security/00773J202) | — | $63.4M | 333.17% |
| ASCENDIS PHARMA A/S | — | $61.8M | 324.45% |
| [ARGENX SE](https://search.stillhousedata.com/security/04016X101) | — | $60.3M | 317.06% |
| [BIOGEN INC](https://search.stillhousedata.com/security/09062X103) | — | $55.7M | 292.47% |
| [ORUKA THERAPEUTICS INC](https://search.stillhousedata.com/security/687604108) | — | $50.4M | 265.03% |
| [Fidelity Revere Street Trust](https://search.stillhousedata.com/security/31635A303) | — | $47.8M | 251.02% |
| [AMGEN INC](https://search.stillhousedata.com/security/031162100) | — | $46.8M | 245.77% |
| [VAXCYTE INC](https://search.stillhousedata.com/security/92243G108) | — | $43.7M | 229.65% |
| [REVOLUTION MEDICINES INC](https://search.stillhousedata.com/security/76155X100) | — | $43.2M | 226.78% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-04-30 | $1.9B |
| 2026-01-31 | $1.9B |
| 2025-10-31 | $1.7B |
| 2025-07-31 | $1.4B |
| 2025-04-30 | $1.4B |
| 2025-01-31 | $1.5B |
| 2024-10-31 | $1.9B |
| 2024-07-31 | $1.8B |

## More

- [Registrant: Fidelity Advisor Series VII](https://search.stillhousedata.com/registrant/315700)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000005321.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.